期刊文献+

糖尿病肾病患者铁代谢的研究 被引量:4

Study on Iron Metabolism in Diabetic Nephropathy Patients
下载PDF
导出
摘要 目的探讨2型糖尿病肾病(DN)患者血清铗(Fe)、转铁蛋白(TRF)、铁蛋白(SF)和尿转铁蛋白(UTF)的变化与临床意义。方法89例DN患者采用免疫化学发光法测定SF,TRF和UTF,免疫比浊法测定胱押素C(CysC)和尿微量清蛋白(mAlb)及化学法测定血清Fe,并与42例2型糖尿病非肾病患者和55倒健康体检者比较。结果2型糖尿病伴肾病组血清Fe,SF,TRF,CysC,UTF和mAlb均显著高于非肾病组和健康对照组(P〈0.01)IDN患者组血清Fe,SF,TRF,UTF与CysC和mAlb呈正相关(P〈0.01)。结论DN患者体内存在以血清Fe,TRF和SF增高为主的铁超负荷,血清Fe,SF,TRF和UTF可作为糖尿病肾损害的早期监测指标。 Objective To investigate the change and the clinical significance of serum iron (Fe),tranferrin (TRF),serum ferritin (SF) and uric tranferrin in type 2 diabetes nephrosis (DN) patients. Methods Serum Fe,SF,TRF,UTF,CysC and mAlb were detected in 89 patients with diabetic nephropathy,and compared with 42 type 2 diabetic mellitus without nephropathy and 55 normal controls. Results Serum Fe,SF,TRF,UTF,CysC and mAlb in type 2 diabetes nephrosis patients were significantly higher than those of type 2 diabetic mellitus without nephropathy grop and normal controls. Serum Fe,SF,TRF and UTF were significant correlatted to CysC and mAlb in diabetic nephropathy. Conclusion These results indicated that there existed iron,transferrin and ferritin increased iron overload in diabetic nephropathy,Fe,SF,TRF and UTF may be as diabetic kidney damage monitoring indicators.
出处 《现代检验医学杂志》 CAS 2011年第4期105-107,共3页 Journal of Modern Laboratory Medicine
关键词 糖尿病肾病 血清铁 转铁蛋白 铁蛋白 diabetic nephropathy serum iron (Fe) tranferrin (TRF) serum ferritin(SF) uric tranferrin (LITF)
  • 相关文献

参考文献7

二级参考文献91

  • 1李永翔,李戈,董维平,陈静,卢大儒,谭建明.大鼠胰岛分离纯化技术的改进[J].复旦学报(医学版),2006,33(2):266-268. 被引量:15
  • 2Ford ES, Cogswell ME. Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care, 1999, 22:1978-1983. 被引量:1
  • 3Ren Y, Tian HM, Li XJ, et al. Elevated serum ferritin concentrations in a glucose-impaired population and in normal glucose tolerant first-degree relatives in familial type 2 diabetic pedigrees. Diabetes Care, 2004, 27 : 622-623. 被引量:1
  • 4Fernandez-Real JM, Garcia Bragado F, Penarroja G, et al. Blood letting in high-ferritin type 2 diabetes. Diabetes Care, 2002, 25:2249-2255. 被引量:1
  • 5Saito K, Ishizaka N, Aizawa T, et al. Iron chelation and a free radical scavenger suppress angiotensin II-induced upregnlation of TGF-β1 in the heart. Am J Physiol Heart Circ Physiol, 2005, 288: 1836-1843. 被引量:1
  • 6Parkes JG, Liu Y, Sirna JB, et al. Changes in gene expression with iron loading and chelation in cardiac myocytes and non-myocytic fibroblasts. J Mol cell Cardiol, 2000, 32:233-246. 被引量:1
  • 7Templeton DM. Genetic regulation of cell function in response to iron overload or chelation. Bioch Biophys Act, 2003, 1619: 113-124. 被引量:1
  • 8Nankivell BJ, Tay YC, Boadle RA, et al. Lysosomal iron accumulation in diabetic nephropathy. Ren Fail, 1994, 16:367- 381. 被引量:1
  • 9Facchini FS, Saylor KL. A low-iron-available, polyphenol-enriched, carbohydrate-restricted diet to slow progression of diabetic nephropathy. Diabetes, 2003,52 : 1204- 1209. 被引量:1
  • 10Ward DT, Hamilton K, Burnand R, et al. Altered expression of iron transport proteins in streptozotoein-indueed diabetic rat kidney. Bioch Biophys Act, 2005, 80: 79-84. 被引量:1

共引文献29

同被引文献70

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部